Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymosin beta 10 pseudogene 2 (TMSB10P2) is classified as a pseudogene in the human genome, designated by the gene ID 100873786[4][2]. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they are typically not transcribed into functional proteins and generally lack known biological function, disease relevance, or use as therapeutic targets[4][2]. TMSB10P2 is distinct from the protein-coding gene Thymosin beta 10 (TMSB10), which is involved in cytoskeletal organization and implicated in several cancers, but TMSB10P2 itself does not encode a functional protein and has no reported biological or clinical significance as a drug target[4][2].\n\nKey Context:\n- TMSB10P2 is a pseudogene related to TMSB10, but the functional and clinical data available about TMSB10 do not apply to TMSB10P2.\n- There is no evidence that TMSB10P2 serves as a therapeutic or biological target, or that it is associated with disease mechanisms, drug interactions, or safety concerns[4][2].\n\nIf you intended to inquire about the protein-coding gene Thymosin beta 10 (TMSB10) rather than its pseudogene TMSB10P2, a distinct summary can be provided.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thymosin beta 10 pseudogene 2 (TMSB10P2).